摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(benzoxazol-2-ylthiomethyl)-2-butyl-5,6,7,8-tetrahydro-2H-isoquinoline-3-thione

中文名称
——
中文别名
——
英文名称
4-(benzoxazol-2-ylthiomethyl)-2-butyl-5,6,7,8-tetrahydro-2H-isoquinoline-3-thione
英文别名
4-(1,3-Benzoxazol-2-ylsulfanylmethyl)-2-butyl-5,6,7,8-tetrahydroisoquinoline-3-thione
4-(benzoxazol-2-ylthiomethyl)-2-butyl-5,6,7,8-tetrahydro-2H-isoquinoline-3-thione化学式
CAS
——
化学式
C21H24N2OS2
mdl
——
分子量
384.566
InChiKey
FOPVEQRGKJKPIX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    26
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    86.7
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Antipruritics
    申请人:Yasui Kiyoshi
    公开号:US20050101590A1
    公开(公告)日:2005-05-12
    It is intended to provide antipruritics (drugs to control itching, antiitch agents and drugs to stop itching). It is found out that a compound having an agonistic activity to the cannabinoid receptor shows an antipruritics effect.
    这意味着它旨在提供止痒药(用于控制瘙痒的药物,抗瘙痒剂和止痒药)。研究发现,具有激动性作用的大麻素受体的化合物具有止痒效果。
  • Pyridone derivatives having affinity for cannabinoid 2-type receptor
    申请人:——
    公开号:US20040082619A1
    公开(公告)日:2004-04-29
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): 1 wherein R 1 is a group represented by the formula: —Y 1 —Y 2 —Y 3 —R a wherein Y 1 is single bond or the like; Y 2 is —C(═O)—NH— or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
    发现具有与cannabinoid 2型受体结合活性的化合物,其代表式为(I):1其中R1是由式表示的基团:—Y1—Y2—Y3—Ra其中Y1是单键或类似物;Y2是—C(═O)—NH—或类似物;Y3是可选取代芳基或类似物;R2是氢或类似物;R3是烷基或类似物;R4是烷基或类似物;R5是可选取代烷基或类似物;或R3和R4与相邻原子结合形成环状基团或类似物。
  • Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
    申请人:Tada Yukio
    公开号:US20060052411A1
    公开(公告)日:2006-03-09
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R 1 is a group represented by the formula: —Y 1 —Y 2 —Y 3 —R a wherein Y 1 is single bond or the like; Y 2 is —C(═O)—NH— or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
    被发现的化合物具有与cannabinoid type 2 受体结合活性,其化学式为(I),其中R1是由公式表示的基团:—Y1—Y2—Y3—Ra,其中Y1是单键或类似物;Y2是—C(═O)—NH—或类似物;Y3是可选择取代的芳基或类似物;R2是氢或类似物;R3是烷基或类似物;R4是烷基或类似物;R5是可选择取代的烷基或类似物;或R3和R4与相邻原子一起形成环状基团或类似物。
  • Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
    申请人:TADA Yukio
    公开号:US20100081686A1
    公开(公告)日:2010-04-01
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R 1 is a group represented by the formula: —Y 1 —Y 2 —Y 3 —R a wherein Y 1 is single bond or the like; Y 2 is —C(═O)—NH— or the like; Y 3 is optionally substituted aryl or the like; R 2 is hydrogen or the like; R 3 is alkyl or the like; R 4 is alkyl or the like; R 5 is optionally substituted alkyl or the like; or R 3 and R 4 taken together with the adjacent atom form cyclic group or the like.
    发现化合物具有与cannabinoid type 2受体结合活性,该化合物的公式为(I):其中R1是由公式表示的基团:—Y1—Y2—Y3—Ra,其中Y1是单键或类似物;Y2是—C(═O)—NH—或类似物;Y3是可选择的取代芳基或类似物;R2是氢或类似物;R3是烷基或类似物;R4是烷基或类似物;R5是可选择的取代烷基或类似物;或R3和R4与相邻原子结合形成环状基团或类似物。
  • PYRIDONE DERIVATIVE HAVING AFFINITY FOR CANNABINOID 2-TYPE RECEPTOR
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1357111A1
    公开(公告)日:2003-10-29
    It was found that the compound having a binding activity to the cannabinoid type 2 receptor represented by the formula (I): wherein R' is a group represented by the formula: -Y1-Y2-Y3Ra wherein Y1 is single bond or the like; Y2 is -C(=O)-NH- or the like; Y3 is optionally substituted aryl or the like; R2 is hydrogen or the like; R3 is alkyl or the like; R4 is alkyl or the like; R5 is optionally substituted alkyl or the like; or R3 and R4 taken together with the adjacent atom form cyclic group or the like.
    研究发现,对大麻素 2 型受体具有结合活性的化合物由式(I)表示: 其中 R' 是由式表示的基团:-其中 Y1 是单键或类似物;Y2 是-C(=O)-NH- 或类似物;Y3 是任选取代的芳基或类似物;R2 是氢或类似物;R3 是烷基或类似物;R4 是烷基或类似物;R5 是任选取代的烷基或类似物;或 R3 和 R4 与相邻原子一起形成环状基团或类似物。
查看更多

同类化合物

(N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) 钙离子载体A23187半镁盐 荧光增白剂EBF 苯并恶唑胺 苯并恶唑的取代物 苯并恶唑甲磺酰氯 苯并恶唑基-2-甲酰基-S-乙基-异缩氨基硫脲 苯并恶唑-2-羧酸酰肼 苯并恶唑-2-磺酸 苯并恶唑-2-甲酸 苯并恶唑-2-甲磺酸钠 苯并恶唑-2-乙酸 苯并恶唑 苯并噁唑-5-甲酸 苯并噁唑-2-羧酸乙酯 苯并噁唑-2-甲醛 苯并噁唑,4,7-二氯-2-(氯甲基)- 苯并噁唑,2-叠氮- 苯并噁唑,2-(氯甲基)-4,7-二氟- 苯并[d]恶唑-7-甲酸甲酯 苯并[d]恶唑-5-硼酸频哪醇酯 苯并[d]噁唑-6-甲醛 苯并[d]噁唑-2-羧酸甲酯 苯并[d]噁唑-2-甲醇 苯并[D]恶唑-7-胺 苯并[D]噁唑-4-基氨基甲酸叔丁酯 苯并[D]噁唑-2-羧酸钾 苯并-13C6-噁唑 离子载体 碘化二氢2-[3-(5,6-二氯-1,3-二乙基-1,3--2H-苯并咪唑-2-亚基)丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 硫代偏糖醛 甲酰胺,N-乙基-N-[6-[(3-甲酰基苯氧基)甲基]-2-苯并噁唑基]- 甲酰胺,N-[6-(溴甲基)-2-苯并噁唑基]-N-乙基- 甲基硫酸1-甲基-8-[(甲基氨基甲酰)氧代]喹啉正离子 甲基6-氨基-1,3-苯并恶唑-2-羧酸酯 甲基2-氨基-1,3-苯并恶唑-5-羧酸酯 甲基1,3-苯并恶唑-2-基乙酸酯 甲基-2-乙基-1,3-苯并唑-5-羧酸乙酯 甲基-1,3-苯并唑-5-羧酸乙酯 环戊二烯并[e][1,3]恶嗪-5,6-二胺 环戊二烯并[d][1,3]恶嗪-6,7-二胺 溴氯唑酮 溴化二氢2-[3-[1-[4-[(乙酰氨基)磺基基]丁基]-5,6-二氯-3-乙基-1,3--2H-苯并咪唑-2-亚基]丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 氰基二硫代亚氨酸(6-氯-2-氧代-3(2H)-苯并恶唑基)甲基甲基酯 氰基-二硫代亚氨酸甲基(2-氧代-3(2H)-苯并恶唑基)甲基酯 氯唑沙宗-2-13C-3-15N-羟基-18O 氯唑沙宗 氯化3-乙基-2-[2-(1-乙基-2,5-二甲基-1H-吡咯-3-基)乙烯基]苯并恶唑翁盐 昂唑司特 拂来星-d2